NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
Key Financials
Operating Income
$-58240445
↓ 715.4%
Revenue
$39990
↓ 51.8%
Net Income
$-62146210
↓ 422.3%
EPS (Diluted)
$-3.20
↓ 363.8%
Total Liabilities
$20.3M
↑ 127.9%
Total Assets
$2.8M
↓ 17.4%
Shareholders' Equity
$-17507729.00
↓ 218.0%
Cash & Equivalents
$58729.00
↓ 9.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 4/16/2026 | View on SEC |
| 8-K | 4/16/2026 | View on SEC |
| 424B5 | 4/16/2026 | View on SEC |
| 4 | 4/13/2026 | View on SEC |
| 3 | 4/13/2026 | View on SEC |
| S-3 | 4/10/2026 | View on SEC |
| 8-K | 4/10/2026 | View on SEC |
| 424B5 | 4/10/2026 | View on SEC |
| 4 | 4/10/2026 | View on SEC |
| EFFECT | 4/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NTHI |
| Company Name | NEONC TECHNOLOGIES HOLDINGS, INC. |
| CIK | 1979414 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 310 663 7831 |